Literature DB >> 26064275

Prevalence of risk factors for diabetic foot complications in a Chinese tertiary hospital.

Liaofang Wu1, Qian Hou2, Qiuhong Zhou1, Fang Peng3.   

Abstract

AIMS: To determine the prevalency of risk factors for diabetic foot complications in diabetic patients free of active ulceration in a hospital setting and to investigate the knowledge of foot care of the patients.
METHODS: A retrospective study was conducted on a cohort of 296 patients with diabetes hospitalized in a tertiary hospital. A convenience sampling was adopted to recruit subjects during 2012/2013. All completed an interviewer-administered questionnaire and underwent medical assessment including foot examination and assessment of presence of peripheral sensory neuropathy (PSN) and peripheral arterial disease (PVD). The patients were assigned to a foot risk category which was developed by the International Working Group on the Diabetic Foot (IWGDF).
RESULTS: 296 inpatients were evaluated. Foot deformity was noticed in 124 patients (42%), hallux valgus was the most prevalent abnormality, found in 65% of patients. Prevalency of neuropathy hypertension, nephropathy and retinopathy were 66.2%, 57.1%, 48.3% and 44.9% respectively. 37 (12.5%) patients had a history of ulceration (n = 33) and/or toe amputation (n = 4). According to the classification system of the IWGDF, 35.1% of patients were considered as having low-risk by the modified IWGDF classification (group 0), and 49% of the study population were at high risk for pedal ulceration (group 2 and 3). There was a clear trend between the increasing severity of the staging and HbA1c, duration of diabetes, prevalence of hypertension, nephropathy and retinopathy and absent of physical activity. The mean knowledge score of foot care was 21.21±3.84.
CONCLUSION: The risk factors for foot ulceration and lack of fool care knowledge was rather common in a hospital-based diabetic population, emphasizing the importance of implementing simple and affordable screening tools and methods to identify high-risk patients and providing foot care education for them.

Entities:  

Keywords:  Diabetic foot; foot care; foot screening; risk factors

Year:  2015        PMID: 26064275      PMCID: PMC4443109     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

Review 1.  Medical treatment of peripheral arterial disease and claudication.

Authors:  W R Hiatt
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

2.  Prevalence of diabetes among men and women in China.

Authors:  Wenying Yang; Juming Lu; Jianping Weng; Weiping Jia; Linong Ji; Jianzhong Xiao; Zhongyan Shan; Jie Liu; Haoming Tian; Qiuhe Ji; Dalong Zhu; Jiapu Ge; Lixiang Lin; Li Chen; Xiaohui Guo; Zhigang Zhao; Qiang Li; Zhiguang Zhou; Guangliang Shan; Jiang He
Journal:  N Engl J Med       Date:  2010-03-25       Impact factor: 91.245

3.  Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.

Authors:  D G Armstrong; L A Lavery; S A Vela; T L Quebedeaux; J G Fleischli
Journal:  Arch Intern Med       Date:  1998-02-09

4.  Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital.

Authors:  Xiang Li; Ting Xiao; Yuzhen Wang; Hongbin Gu; Zhiguo Liu; Yufeng Jiang; Yanjun Liu; Zuqian Lu; Xiaopin Yang; Yin Lan; Zhangrong Xu
Journal:  Diabetes Res Clin Pract       Date:  2011-04-03       Impact factor: 5.602

5.  An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes.

Authors:  Dean T Williams; Keith G Harding; Patricia Price
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

Review 6.  Preventing foot ulcers in patients with diabetes.

Authors:  Nalini Singh; David G Armstrong; Benjamin A Lipsky
Journal:  JAMA       Date:  2005-01-12       Impact factor: 56.272

7.  The international consensus and practical guidelines on the management and prevention of the diabetic foot.

Authors:  Nicolaas C Schaper; Jan Apelqvist; Karel Bakker
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 4.810

8.  Prevalence of risk factors for diabetic foot complications.

Authors:  Fatma Al-Maskari; Mohammed El-Sadig
Journal:  BMC Fam Pract       Date:  2007-10-10       Impact factor: 2.497

9.  Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists.

Authors:  Andrew J M Boulton; David G Armstrong; Stephen F Albert; Robert G Frykberg; Richard Hellman; M Sue Kirkman; Lawrence A Lavery; Joseph W Lemaster; Joseph L Mills; Michael J Mueller; Peter Sheehan; Dane K Wukich
Journal:  Diabetes Care       Date:  2008-08       Impact factor: 19.112

Review 10.  Inpatient management of diabetic foot disorders: a clinical guide.

Authors:  Dane K Wukich; David G Armstrong; Christopher E Attinger; Andrew J M Boulton; Patrick R Burns; Robert G Frykberg; Richard Hellman; Paul J Kim; Benjamin A Lipsky; James C Pile; Michael S Pinzur; Linda Siminerio
Journal:  Diabetes Care       Date:  2013-09       Impact factor: 19.112

View more
  3 in total

1.  Prevalence and associated factors of foot ulcer among diabetic patients in Ethiopia: a systematic review and meta-analysis.

Authors:  Tadesse Tolossa; Belayneh Mengist; Diriba Mulisa; Getahun Fetensa; Ebisa Turi; Amanuel Abajobir
Journal:  BMC Public Health       Date:  2020-01-10       Impact factor: 3.295

2.  Prevalence of Foot At-Risk and its Associated Characteristics among Outpatients with Diabetes Mellitus in a Peruvian Public Hospital.

Authors:  Marlon Yovera-Aldana; Sonia Pérez-Cavero; Isabel Pinedo-Torres; Carlos Zubiate-López
Journal:  Rev Diabet Stud       Date:  2022-03-09

3.  Risk assessment for foot ulcers among Tunisian subjects with diabetes: a cross sectional outpatient study.

Authors:  B Zantour; S Bouchareb; Z El Ati; F Boubaker; W Alaya; W Kossomtini; M H Sfar
Journal:  BMC Endocr Disord       Date:  2020-08-24       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.